INO

$1.66-12.17%visit website

INOVIO PHARMACEUTICALS, INC.

Market Cap

$172M

Live price × SEC shares (Aug 10, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.71

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

39.3

Mkt cap / shareholders' equity

Flagged input, hover for details

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	0.00	0.00	0.00	0.00	0.00
Research & development	13,333	10,261	14,070	10,827	48,491
Total operating expenses	21,210	17,477	21,950	18,625	79,262
Operating income	(21,210)	(17,477)	(21,950)	(18,625)	(79,262)
Interest expense	0.00	0.00
Net income	(45,497)	3,765	(19,683)	(6,012)	(67,427)
EPS (basic) ($)	(0.87)		(0.28)	(0.07)	—
EPS (diluted) ($)	(0.87)		(0.28)	(0.07)	—
Weighted avg. shares (basic)	52,169		69,102	81,619
Weighted avg. shares (diluted)	52,169		69,102	81,619

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 12, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

14 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Nov 2, 2026 accepted 7:15 AM ET	7.01Reg FD disclosure8.01Other events	Document SEC ↗
Oct 6, 2026 accepted 4:06 PM ET	5.03Bylaws / fiscal year	Document SEC ↗
Aug 12, 2026 accepted 4:07 PM ET	2.02Earnings release	Document SEC ↗
Jul 31, 2026 accepted 7:23 AM ET	1.01Material agreement8.01Other events	Document SEC ↗
Jul 29, 2026 accepted 4:03 PM ET	2.02Earnings release	Document SEC ↗
May 20, 2026 accepted 4:01 PM ET	5.03Bylaws / fiscal year5.07Shareholder vote	Document SEC ↗
May 13, 2026 accepted 4:07 PM ET	2.02Earnings release	Document SEC ↗
Apr 6, 2026 accepted 7:03 AM ET	1.01Material agreement8.01Other events	Document SEC ↗
Apr 2, 2026 accepted 6:15 AM ET	8.01Other events	Document SEC ↗
Mar 12, 2026 accepted 4:07 PM ET	2.02Earnings release	Document SEC ↗